VaramirStart free · no cardSign in
KURA as of Nov 3 · 13:04 ET
KURANasdaqPharmaceutical Preparations

Kura Oncology, Inc. · Brief

Next report

Today

Nov 3 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±18.0%
avg realized
±2.2%
Feb 26 '25±9.6%▼−1.54%×0.16
May 1 '25±8.2%▼−0.31%×0.04
Aug 7 '25±38.8%▼−7.05%×0.18
Q3 FY25±19.4%▲+1.94%×0.10
Jan 12 '26±6.4%▼−2.55%×0.40
Q1 FY26±11.2%▼−0.47%×0.04
May 12 '26±40.6%▼−2.07%×0.05
Q2 FY26±10.2%▲+1.51%×0.15
quarterimplied−45%0+45%realized×
Q2 FY26±10.2%▲+1.51%×0.15
May '26±40.6%▼−2.07%×0.05
Q1 FY26±11.2%▼−0.47%×0.04
Jan '26±6.4%▼−2.55%×0.40
Q3 FY25±19.4%▲+1.94%×0.10
Aug '25±38.8%▼−7.05%×0.18
2 older reports
May '25±8.2%▼−0.31%×0.04
Feb '25±9.6%▼−1.54%×0.16
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · est.

Bull2 of 3

3disclosed supplier and customer ties in SEC filingsSEC filings
220managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

8 of 8recent reports where the move came in under the options implied rangeEarnings history
9 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

KURA report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 20impliedImplied move: ±33.2% into Nov 3 earnings (Oct 20 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.